BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28439954)

  • 41. Treatment of distal deep vein thrombosis.
    Kirkilesis G; Kakkos SK; Bicknell C; Salim S; Kakavia K
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013422. PubMed ID: 32271939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60.
    Anand SS
    Vasc Med; 2001 Nov; 6(4):269-70. PubMed ID: 11958396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism.
    Douketis JD; Gu CS; Schulman S; Ghirarduzzi A; Pengo V; Prandoni P
    Ann Intern Med; 2007 Dec; 147(11):766-74. PubMed ID: 18056660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Venous Thromboembolism Recurrence in Latvian Population: Single University Hospital Data.
    Ģībietis V; Kigitoviča D; Strautmane S; Meilande K; Kalējs VR; Zaičenko A; Maķe K; Lejnieks A; Skride A
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438542
    [No Abstract]   [Full Text] [Related]  

  • 45. Six-week low-molecular-weight heparin versus 12-week warfarin for calf deep vein thrombosis: A randomized, prospective, open-label study.
    Sartori M; Iotti M; Camporese G; Siragusa S; Imberti D; Bucherini E; Corradini S; Ageno W; Prandoni P; Ghirarduzzi A
    Am J Hematol; 2024 May; 99(5):854-861. PubMed ID: 38375893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Analysis of characteristics of the location of lower extremity deep vein thrombosis and the site of pulmonary embolism in hospitalized patients].
    Wu J; Wang X; Jiang W; Li X; Wang M; Wang H; Wang Q; Chen Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1148-1153. PubMed ID: 36567557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of deep vein thrombosis in patients presenting with acute symptomatic pulmonary embolism.
    Jiménez D; Aujesky D; Díaz G; Monreal M; Otero R; Martí D; Marín E; Aracil E; Sueiro A; Yusen RD;
    Am J Respir Crit Care Med; 2010 May; 181(9):983-91. PubMed ID: 20110556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
    Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrence Risk after First Symptomatic Distal versus Proximal Deep Vein Thrombosis According to Baseline Risk Factors.
    Valerio L; Ambaglio C; Barone M; Ciola M; Konstantinides SV; Mahmoudpour SH; Picchi C; Pieresca C; Trinchero A; Barco S
    TH Open; 2019 Jan; 3(1):e58-e63. PubMed ID: 31249983
    [No Abstract]   [Full Text] [Related]  

  • 53. Presence of lower limb deep vein thrombosis and prognosis in patients with symptomatic pulmonary embolism: preliminary report.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Feb; 37(2):225-31. PubMed ID: 18922710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retrospective review of D-dimer testing for venous thrombosis recurrence risk stratification: is this a useful test in the real world?
    Wang J; Tacey M; Ho P
    J Thromb Thrombolysis; 2020 May; 49(4):562-571. PubMed ID: 32253709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. External validation of the DASH prediction rule: a retrospective cohort study.
    Tosetto A; Testa S; Martinelli I; Poli D; Cosmi B; Lodigiani C; Ageno W; De Stefano V; Falanga A; Nichele I; Paoletti O; Bucciarelli P; Antonucci E; Legnani C; Banfi E; Dentali F; Bartolomei F; Barcella L; Palareti G
    J Thromb Haemost; 2017 Oct; 15(10):1963-1970. PubMed ID: 28762665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
    Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G;
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.
    Kearon C
    J Thromb Thrombolysis; 2011 Apr; 31(3):295-300. PubMed ID: 21331558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.
    Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A
    J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High Risk of Venous Thromboembolism After Surgery for Long Bone Metastases: A Retrospective Study of 682 Patients.
    Groot OQ; Ogink PT; Janssen SJ; Paulino Pereira NR; Lozano-Calderon S; Raskin K; Hornicek F; Schwab JH
    Clin Orthop Relat Res; 2018 Oct; 476(10):2052-2061. PubMed ID: 30179923
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.